Creative Medical Technology Holdings (CELZ) Other Non-Current Liabilities (2016 - 2021)
Creative Medical Technology Holdings (CELZ) posted quarterly Other Non-Current Liabilities of $248097.0 for Q2 2021, down 57.08% year-over-year from $578052.0 in Q2 2020, and down 89.1% quarter-over-quarter from $2.3 million in Q1 2021.
Creative Medical Technology Holdings (CELZ) Other Non-Current Liabilities (2016 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Other Non-Current Liabilities for 6 consecutive years, with $248097.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Other Non-Current Liabilities fell 57.08% year-over-year to $248097.0; the TTM figure through Jun 2021 stood at $248097.0 (down 57.08% YoY), while the FY2020 annual figure was $38.7 million, up 465.75% from the prior year.
- Other Non-Current Liabilities slipped to $248097.0 in Q2 2021 per CELZ's latest filing, from $2.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $38.7 million in Q4 2020 and bottomed at $1932.0 in Q1 2017.
- Historically, Other Non-Current Liabilities has averaged $3.5 million across 5 years, with a median of $621661.0 in 2017.
- Annual changes were most pronounced in 2017 — Other Non-Current Liabilities soared 62500.75% — and 2019, when it tumbled 58.73%.
- Creative Medical Technology Holdings' Other Non-Current Liabilities stood at $3211.0 in 2017, then jumped by 99718.84% to $3.2 million in 2018, then soared by 113.65% to $6.8 million in 2019, then jumped by 465.75% to $38.7 million in 2020, then sank by 99.36% to $248097.0 in 2021.
- Business Quant data shows CELZ's Other Non-Current Liabilities at $248097.0 in Q2 2021, $2.3 million in Q1 2021, and $38.7 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Creative Medical Technology Holdings | 1.88 Mn | 1.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 248,097.00 |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | 38.74 Mn |
| Sep 30, 2020 | 852,523.00 |
| Jun 30, 2020 | 578,052.00 |
| Mar 31, 2020 | 286,409.00 |
| Dec 31, 2019 | 6.85 Mn |
| Sep 30, 2019 | 1.32 Mn |
| Jun 30, 2019 | 783,311.00 |
| Mar 31, 2019 | 658,005.00 |
| Sep 30, 2018 | 3.21 Mn |
| Mar 31, 2018 | 3,704.00 |
| Dec 31, 2017 | 3,211.00 |
| Sep 30, 2017 | 585,317.00 |
| Jun 30, 2017 | 2,203.00 |
| Mar 31, 2017 | 1,932.00 |
| Dec 31, 2016 | 1,439.00 |
| Sep 30, 2016 | 935.00 |